Background: Neuroinflammatory processes are common in neurodegenerative diseases
such as Alzheimer's disease (AD) and frontotemporal dementia (FTD), but current …

Background Neuroinflammation has gained increasing attention as a potential contributing
factor in Alzheimer's disease (AD) pathology. A clinical cerebrospinal fluid biomarker …

Inflammatory markers have been shown to predict neurocognitive outcomes in aging adults;
however, the degree to which peripheral markers mirror the central nervous system remains …

Objective Inflammation plays a crucial role in the pathogenesis of mild cognitive impairment
(MCI) and Alzheimer's disease (AD). Our study aimed to analyse previous inconsistent …

Background In vitro and animal studies have linked neuroinflammation to Alzheimer's
disease (AD) pathology. Studies on markers of inflammation in subjects with mild cognitive …

Cumulative data suggest that neuroinflammation plays a prominent role in Alzheimer's
disease (AD) pathogenesis. The purpose of this work was to assess if patients with AD …

It has been suggested that a number of molecules associated with inflammation are involved
in the pathogenesis of Alzheimer's disease (AD). We measured the levels of α1 …

Background Chronically dysregulated neuroinflammation has been implicated in
neurodegenerative dementias, with separate studies reporting increased brain levels of …

Abstract Background In neurodegenerative dementias (NDs) such as prion disease,
Alzheimer's disease (AD), and frontotemporal lobar degeneration (FTLD), protein misfolding …

Neuroinflammation is involved in the pathology of Alzheimer's disease (AD). Our major focus
was to clarify whether neuroinflammation plays an important role in AD pathogenesis …